ES489222A0 - Un procedimiento para preparar un compuesto de guanidinotia-zol - Google Patents

Un procedimiento para preparar un compuesto de guanidinotia-zol

Info

Publication number
ES489222A0
ES489222A0 ES489222A ES489222A ES489222A0 ES 489222 A0 ES489222 A0 ES 489222A0 ES 489222 A ES489222 A ES 489222A ES 489222 A ES489222 A ES 489222A ES 489222 A0 ES489222 A0 ES 489222A0
Authority
ES
Spain
Prior art keywords
guanidinotia
zol
preparing
procedure
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES489222A
Other languages
English (en)
Spanish (es)
Other versions
ES8103070A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2574579A external-priority patent/JPS55118476A/ja
Priority claimed from JP7950879A external-priority patent/JPS565469A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES8103070A1 publication Critical patent/ES8103070A1/es
Publication of ES489222A0 publication Critical patent/ES489222A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ES489222A 1979-03-06 1980-03-05 Un procedimiento para preparar un compuesto de guanidinotia-zol Granted ES489222A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2574579A JPS55118476A (en) 1979-03-06 1979-03-06 Novel amidine derivative and its preparation
JP7950879A JPS565469A (en) 1979-06-23 1979-06-23 Novel amidine derivative and its preparation
KR1019800000932A KR830002478B1 (ko) 1979-03-06 1980-03-06 구아니디노 티아졸 화합물의 제조방법

Publications (2)

Publication Number Publication Date
ES8103070A1 ES8103070A1 (es) 1981-02-16
ES489222A0 true ES489222A0 (es) 1981-02-16

Family

ID=27285138

Family Applications (1)

Application Number Title Priority Date Filing Date
ES489222A Granted ES489222A0 (es) 1979-03-06 1980-03-05 Un procedimiento para preparar un compuesto de guanidinotia-zol

Country Status (11)

Country Link
US (1) US4362736A (en, 2012)
CA (1) CA1145345A (en, 2012)
CH (1) CH644114A5 (en, 2012)
DE (1) DE3008056A1 (en, 2012)
ES (1) ES489222A0 (en, 2012)
FR (1) FR2450827A1 (en, 2012)
GB (1) GB2052478B (en, 2012)
IT (1) IT1165509B (en, 2012)
NL (1) NL8001361A (en, 2012)
PH (1) PH16099A (en, 2012)
SE (1) SE447253B (en, 2012)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196923A (en) * 1980-04-29 1983-12-16 Shionogi & Co 2-guanidino-4-(-acylaminoalkyl(thio)methyl)thiazoles and analogs
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
IN158869B (en, 2012) * 1981-03-18 1987-02-07 Ici Plc
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
JPS5872571A (ja) * 1981-10-27 1983-04-30 Shionogi & Co Ltd 2−グアニジノ−4−〔2−(ホルムアミド)エチルチオメチル〕チアゾ−ルの製法
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
EP0103390A3 (en) * 1982-08-13 1986-02-26 Imperial Chemical Industries Plc Guanidine-containing esters as histamine h2 receptor blockers
DE3238867A1 (de) * 1982-10-20 1984-04-26 Ludwig Heumann & Co GmbH, 8500 Nürnberg Heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59104370A (ja) * 1982-12-03 1984-06-16 Kotobuki Seiyaku Kk チアゾ−ル誘導体及びその製造方法
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規2−グアニジノチアゾリン誘導体ならびにその製造法
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
JPS6160673A (ja) * 1984-08-30 1986-03-28 Yamanouchi Pharmaceut Co Ltd グアニジノチアゾ−ル誘導体の製造法
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
DE3786030T2 (de) 1986-03-27 1993-12-02 Merck Frosst Canada Inc Tetrahydrocarbazole Ester.
EP0284536A1 (en) * 1987-02-20 1988-09-28 Centro Marga Para La Investigacion S.A. A process for the preparation of 3-(2-guanidinothiazol-4-yl-methylthio)propionitrile
US5428033A (en) 1990-10-12 1995-06-27 Merck Frosst Canada, Inc. Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5410054A (en) * 1993-07-20 1995-04-25 Merck Frosst Canada, Inc. Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
JP6378179B2 (ja) 2013-07-03 2018-08-22 株式会社新日本科学 新規化合物,有機カチオントランスポーター3の検出剤及び活性阻害剤
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
WO2021183259A1 (en) * 2020-03-12 2021-09-16 Nanopharmaceutics, Inc. Famotidine and famotidine analogs for corona virus treatment
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817078C2 (de) * 1977-04-20 1995-06-14 Zeneca Ltd Guanidinderivate
NO781300L (no) * 1977-04-20 1978-10-23 Ici Ltd Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法

Also Published As

Publication number Publication date
PH16099A (en) 1983-06-24
FR2450827B1 (en, 2012) 1983-03-25
IT8067346A0 (it) 1980-03-05
IT1165509B (it) 1987-04-22
ES8103070A1 (es) 1981-02-16
NL8001361A (nl) 1980-09-09
GB2052478B (en) 1983-04-07
DE3008056C2 (en, 2012) 1988-07-21
CH644114A5 (de) 1984-07-13
GB2052478A (en) 1981-01-28
CA1145345A (en) 1983-04-26
FR2450827A1 (fr) 1980-10-03
DE3008056A1 (de) 1980-09-18
US4362736A (en) 1982-12-07
SE8001691L (sv) 1980-09-07
SE447253B (sv) 1986-11-03

Similar Documents

Publication Publication Date Title
ES496948A0 (es) Un procedimiento para preparar compuestos de cefem
ES489222A0 (es) Un procedimiento para preparar un compuesto de guanidinotia-zol
ES495376A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
AR226837A1 (es) Un procedimiento para la obtencion de un aglutinante histico
ES490503A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES489629A0 (es) Procedimiento para preparar un derivado de benzamida
ES484270A0 (es) Un procedimiento para preparar compuestos de cefem
ES497302A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES503134A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES505498A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES505496A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
AR226127A1 (es) Procedimiento para producir un compuesto de piran-4-ona
ES494629A0 (es) Un procedimiento para preparar compuestos de tiofosfonato nosimetricos
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
ES496859A0 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
MX5142E (es) Procedimiento mejorado para preparar un compuesto de cefalosporina
ES488808A0 (es) Un procedimiento para preparar derivados de fenotiazina
ES505714A0 (es) Un procedimiento para preparar compuestos de cefem
ES498168A0 (es) Un procedimiento para preparar alcohilfosfonoditioato de al-cohilo
AR224652A1 (es) Un procedimiento para preparar derivados de decahidroquinolinol
ES492210A0 (es) Un procedimiento para preparar b-cloroalanina
ES494328A0 (es) Un procedimiento para preparar 5-halogenopirimidina